Oral [spco]
Class III [inpr]
ANTIARRHYTHMICS [phsu]
New [tmco]
Purpose [ftcn]
Review [inpr]
This [euka]
Review [inpr]
Late [tmco]
development [phsf]
Clinical [qlco]
Usage [ftcn]
Class III [inpr]
ANTIARRHYTHMICS [phsu]
New [tmco]
studies [lbpr]
Provide [acty]
Insight [menp]
Mechanism [ftcn]
Action [ftcn]
Drugs [phsu]
Recent [tmco]
finding new [fndg]
Data [idcn]
Suggest [idcn]
Amiodarone [orch, phsu]
One [qnco]
Most [qnco]
effective [qlco]
Drugs [phsu]
Management [ocac]
ventricular [bpoc]
Supraventricular tachyarrhythmias [patf]
Over [spco]
learned [menp]
To [qlco]
Toxic effect [inpo]
Side [spco]
Drug [phsu]
Risk [qlco]
bradyarrhythmias [dsyn]
Placement [hlca]
pacemaker [medd]
More [ftcn]
Sotalol [orch, phsu]
Approved [qlco]
treatment [ftcn]
Atrial Fibrillation [patf]
Atrial Flutter [patf]
Found [qnco]
To [qlco]
effective [qlco]
Management [ocac]
Postoperative [tmco]
Atrial Flutter [patf]
dofetilide [orch, phsu]
Approved [qlco]
Conversion [ftcn]
Maintenance [acty]
Sinus rhythm [fndg]
Atrial Flutter [patf]
Role [socb]
Ventricular arrhythmias [patf]
Data [idcn]
Clinical [qlco]
Efficacy [qlco]
azimilide [orch, phsu]
dronedarone [orch, phsu]
summary [inpr]
Management [ocac]
Arrhythmias [patf]
Patients [podg]
Structural [spco]
Heart disease [dsyn]
Challenge [clna]
Class III [inpr]
ANTIARRHYTHMICS [phsu]
treatment [ftcn]
Group [idcn]
Patients [podg]
